Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Phosphagenics Limited Stories

2014-03-26 08:23:34

Management to Detail the Commercialization of High Value Pain Products including Oxycodone using its TPM® Topical Drug Delivery Technology MELBOURNE, Australia, March 26, 2014 /PRNewswire/ --Phosphagenics Limited (ASX: POH) (OTCQX: PPGNY) ("Phosphagenics" or "the Company") announced today that management will host an investor conference call and webcast to discuss the commercial opportunities arising from a range of innovative analgesic products emerging from the Company's...

2013-10-24 08:34:29

MELBOURNE, Australia, Oct. 24, 2013 /PRNewswire/ -- -- Oxymorphone patch achieves world first therapeutic plasma concentrations in all subjects in clinical trial -- Results from Phase 1 oxymorphone patch clinical trial demonstrates excellent drug delivery profile -- Most commercially significant trial result ever achieved by Phosphagenics as it proves the concept for an estimated $1 billion annual sales -- Phase 2 study to proceed focusing...

2013-05-20 08:26:51

MELBOURNE, Australia, May 20, 2013 /PRNewswire/ -- Collaboration with the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) in treatment of mastitis Major global market opportunity Trials to begin in the second half 2013 Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate with the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) to develop and trial products...

2012-08-01 02:26:59

MELBOURNE, Australia, Aug. 1, 2012 /PRNewswire-Asia/ -- Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has appointed US pharmaceutical consulting company, Neura Group LLC, the consulting unit of the pain specialty company, Neura Therapeutik LLC, to provide strategic commercial and development advice for its TPM/oxycodone patch development program. The pain specialty company, established by former Johnson & Johnson, Pfizer and King...

2009-05-29 08:26:00

- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of Oxycodone MELBOURNE, Australia, May 29 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system. The results of the preclinical studies demonstrated that by incorporating TPM/oxycodone into innovative patch...

2008-12-08 08:33:00

Trial Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical Anaesthetic Xylocaine(R) MELBOURNE, Australia, Dec. 8 /PRNewswire-FirstCall/ --Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of a phase 1 clinical trial that examined the ability of its patented drug delivery system, TPM, to topically deliver the pain relief drug, lidocaine, safely into humans. The trial demonstrated that the patented lidocaine...